Skip to main content

Advertisement

SpringerLink
Log in

Aggressive giant cell granuloma of the jaws treated with interferon alpha: a report of two cases

  • Review Article
  • Published:
Irish Journal of Medical Science Aims and scope Submit manuscript

Abstract

Background

Giant cell granulomas (GCGs) are benign tumours of the jaws of unknown aetiology. Aggressive lesions are difficult to manage and demonstrate a tendency to recur after surgical curettage. In the early 1980s, interferon alpha-2a was found to inhibit angiogenesis through a series of laboratory experiments and was subsequently used to treat a child with pulmonary haemangiomatosis. It has been hypothesised that GCGs are proliferative vascular lesions and would, therefor, be expected to respond to antiangiogenic therapy. The purpose of this study is to report a treatment protocol consisting of enucleation, followed by subcutaneous interferon alpha.

Methods

Patients with a biopsy-confirmed giant cell lesion satisfying criteria for “aggressive” giant cell tumours were included. All lesions were enucleated, and the patients commenced interferon alpha-2a (3,000,000 units/m2) 48–72 h post-operatively.

Results

Two patients satisfied the criteria for aggressive giant cell lesions. All tumours were enucleated. There were no post-operative complications, and all patients tolerated the interferon therapy well. To date, there has been no evidence of tumour recurrence. The follow-up periods were 144 and 81 months, respectively.

Conclusion

Antiangiogenic therapy, in combination with curettage, has proven to be a useful strategy for the management of these tumours. The use of interferon alpha-2a, following enucleation of these lesions, resulted in complete remission of all lesions, and decreased operative morbidity compared with conventional treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Austin LT, Dahlin CD, Royer QR (1959) Giant cell reparative granuloma and related conditions affecting the jawbones. Oral Surg Oral Med Oral Pathol 12:1285–1295

    Article  PubMed  Google Scholar 

  2. Cohen M, Hertzanu Y (1988) Radiologic features, including those seen with computed tomography, of central giant cell granuloma of the jaws. Oral Surg Oral Med Oral Pathol 65:255

    Article  PubMed  CAS  Google Scholar 

  3. Whitaker SB, Waldron CA (1993) Central giant cell lesions of the jaws. Oral Surg Oral Med Oral Pathol 75:199–208

    Article  PubMed  CAS  Google Scholar 

  4. de Lange J, van den Akker HP, Klip H (2004) Incidence and disease free survival after surgical therapy of central giant cell granulomas of the jaws in The Netherlands; 1990–1995. Head Neck 26:792–795

    Article  PubMed  Google Scholar 

  5. Jaffe HL (1953) Giant-cell reparative granuloma, traumatic bone cyst, and fibrous (fibro-osseous) dysplasia of the jaw bones. Oral Surg 6:159–175

    Article  PubMed  CAS  Google Scholar 

  6. Auclair Pl, Cuenin P, Kratochyil FJ, Slater LJ, Ellis GL (1988) A clinical and histomorphologic comparison of the central giant cell granuloma and the giant cell tumour. Oral Surg Oral Med Oral Pathol 66:197–208

    Article  PubMed  CAS  Google Scholar 

  7. Marx RE, Stern D (2002) Oral and maxillofacial pathology. Quintessence Publishing Co Ltd, Chicago

    Google Scholar 

  8. Cohen MM Jr, Gorlin RJ (1991) Noonan-like/multiple giant cell lesion syndrome. Am J Med Genet 40:159

    Article  PubMed  Google Scholar 

  9. de Lange J, van der Akker HP, van der Berg H (2007) Central giant cell granuloma of the jaw: a review of the literature with emphasis on therapy options. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 104:603–615

    Article  PubMed  Google Scholar 

  10. Ficarra G, Sapp P, Eversole LR (1993) Multiple peripheral odontogenic fibroma, World Health Organization type, and giant cell granuloma: a report of an unusual association. J Oral Maxillofac Surg 51:325–328

    Article  PubMed  CAS  Google Scholar 

  11. Ardekian L, Manor R, Peled M, Laufer D (1999) Bilateral central giant cell granulomas in a patient with neurofibromatosis: report of a case and review of the literature. J Oral Maxillofac Surg 57:869–872

    Article  PubMed  CAS  Google Scholar 

  12. Edwards PC, Fantasia JE, Saini T, Rosenberg TJ, Sachs SA, Ruggiero S (2006) Clinically aggressive central giant cell granulomas in two patients with neurofibromatosis 1. Ora Surg Oral Med Oral Pathol Oral Radiol Endod 102:765–772

    Article  Google Scholar 

  13. Ueki Y, Tiziani V, Santanna C et al (2001) Mutations in the gene encoding c-Abl-binding protein SH3BP2 causes cherubism. Nat Genet 28:125–126

    Article  PubMed  CAS  Google Scholar 

  14. Ucar B, Okten A, Mocan H, Ercin C (1998) Noonan syndrome associated with central giant cell granuloma. Clin Genet 53:411–414

    Article  PubMed  CAS  Google Scholar 

  15. Hyckel P, Berndt A, Schleier P et al (2005) Cherubism-new hypothesis on pathogenesis and therapeutic consequences. J Craniomaxillofac Surg 33:61–68

    Article  PubMed  Google Scholar 

  16. Miah SM, Hatani T, Qu X, Yamamura H, Sada K (2004) Point mutations of 3BP2 identified in human inherited disease cherubism result in the loss of function. Genes Cells 9:993–1004

    Article  PubMed  CAS  Google Scholar 

  17. Idowu BD, Thomas G, Frow R et al (2008) Mutations in SH3BP2, the cherubism gene, were not detected in central or peripheral giant cell tumors of the jaw. Br J Oral Maxillofac Surg 46:229

    Article  PubMed  Google Scholar 

  18. Schütz P, El-Bassuoni KH, Munish J, Hamed HH, Padwa BL (2010) Aggressive central giant cell granuloma of the mandible. J Oral Maxillofac Surg 68(10):2537–2544

    Article  PubMed  Google Scholar 

  19. Liu B, Yu S-F, Li T-J (2003) Multinucleated giant cells in various forms of giant cell containing lesions of the jaws express features of osteoclasts. J Oral Pathol Med 32:367

    Article  PubMed  Google Scholar 

  20. Vered M, Buchner A, Dayan D (2006) Immunohistochemical expression of glucocorticoid and calcitonin receptors as a tool for selecting therapeutic approach in central giant cell granuloma of the jaw bones. Int J Oral Maxillofac Surg 35:756–760

    Article  PubMed  CAS  Google Scholar 

  21. Tiffee JC, Aufdemorte TB (1997) Markers for macrophage and osteoclast lineages in giant cell lesions of the oral cavity. J Oral Maxillofac Surg 55:1108–1112

    Article  PubMed  CAS  Google Scholar 

  22. Itonaga I, Hussein I, Kudo O et al (2003) Cellular mechanisms of osteoclast formation and lacunar resorption in giant cell granuloma of the jaw. J Oral Pathol Med 32:224–231

    Article  PubMed  CAS  Google Scholar 

  23. Vered M, Buchner A, Dayan D (2006) Giant cell granuloma of the jaw bones- a proliferative vascular lesion? Immunohistochemical study with vascular endothelial growth factor and basic fibroblast growth factor. J Oral Pathol Med 53:613–619

    Article  Google Scholar 

  24. Chuong R, Kaban LB, Kozakewich H, Perez-Atayde A (1986) Central giant cell lesions of the jaw: a clinicopathologic study. J Oral Maxillofac Surg 44:708–713

    Article  PubMed  CAS  Google Scholar 

  25. Rawashdeh M, Bataineh A, Al-Khateeb T (2006) Long-term clinical and radiological outcomes of surgical management of central giant cell granuloma of the maxilla. Int J Oral Maxillofac Surg 35:60–66

    Article  PubMed  CAS  Google Scholar 

  26. Kaffe I, Ardekian L, Taicher S, Littner MM, Buchner A (1996) Radiologic features of central giant cell granuloma of the jaws. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 81:720–726

    Article  PubMed  CAS  Google Scholar 

  27. Eckardt A, Pogrel MA, Kaban LB et al (1989) Central giant cell granulomas of the jaws: nuclear DNA analysis using image cytometry. Int J Oral Maxillofac Surg 18:3

    Article  PubMed  CAS  Google Scholar 

  28. Ficarra G, Kaban LB, Hansen LS (1987) Central giant cell lesions of the mandible and maxilla: a clinicopathologic and cytometric study. Oral Surg Oral Med Oral Pathol 64:44

    Article  PubMed  CAS  Google Scholar 

  29. O’Malley M, Pogrel MA, Stewart JC et al (1997) Central giant cell granulomas of the jaws: phenotype and proliferation-associated markers. J Oral Pathol Med 26:159

    Article  PubMed  Google Scholar 

  30. Dewsnup NC, Susarla SM, Abulikemu M et al (2008) Immunohistochemical evaluation of giant cell tumors of the jaws using CD34 density analysis. J Oral Maxillofac Surg 66:928

    Article  PubMed  Google Scholar 

  31. Webb DJ, Brockbank J (1986) Combined curettage and cryosurgical treatment for the aggressive “giant cell lesion” of the mandible. Int J Oral Maxillofac Surg 5:780

    Article  Google Scholar 

  32. Eisenbud L, Stern M, Rothberg M et al (1988) Central giant cell granuloma of the jaws: experiences in the management of thirty-seven cases. J Oral Maxillofac Surg 46:376–384

    Article  PubMed  CAS  Google Scholar 

  33. Kruse-Losler B, Diallo R, Gaertner C, Mischke KL, Joos U, Kleinheinz J (2006) Central giant cell granuloma of the jaws: a clinical, radiologic and histopathologic study of 26 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 101:346–354

    Article  PubMed  Google Scholar 

  34. Kaban LB, Troulis MJ, Wilkinson MJ et al (2007) Adjuvant antiangiogenic therapy for giant cell tumors of the jaws. J Oral Maxillofac Surg 65:2018

    Article  PubMed  Google Scholar 

  35. Minic A, Stajcic Z (1996) Prognostic significance of cortical perforation in the recurrence of central giant cell granulomas of the jaws. J Craniomaxillofac Surg 24:104

    Article  PubMed  CAS  Google Scholar 

  36. Bataineh A, Al-Khateeb T, Rawashdeh M (2002) The surgical treatment of central giant cell granuloma of the mandible. J Oral Maxillofac Surg 60:756–761

    Article  PubMed  Google Scholar 

  37. Flanagan AM, Nui B, Tinkler SMB et al (1988) The multinucleate cells in the giant cell granulomas of the jaw are osteoclasts. Cancer 62:1139

    Article  PubMed  CAS  Google Scholar 

  38. Pharoah MJ, Heersche JNM (1986) Dexamethasone inhibits formation of osteoclast-like cells in bone-marrow cultures. J Dent Res 65:1006

    Article  PubMed  CAS  Google Scholar 

  39. Jacoway JR, Howell FV, Terry BC (1988) Central giant cell granuloma—an alternative to surgical therapy (abstract). Oral Surg Oral Med Oral Pathol 66:572

    Google Scholar 

  40. Kermer C, Millesi W, Watzke IM (1994) Local injection of corticosteroids for central giant cell granuloma. A case report. Int J Oral Maxillofac Surg 23:366–368

    Article  PubMed  CAS  Google Scholar 

  41. Terry BC, Jacoway JR (1994) Management of giant cell lesions. Oral maxillofac Surg Clin N Am 6:579–600

    Google Scholar 

  42. Rajeevan NS, Soumithran CS (1998) Intralesional corticosteroid injection for central giant cell granuloma: a case report. Int J Oral Maxillofac Surg 27:303

    Article  PubMed  CAS  Google Scholar 

  43. Comert E, Turanli M, Ulu S (2006) Oral and intralesional steroid therapy in giant cell granuloma. Acta Otolaryngol 26:664

    Article  Google Scholar 

  44. Kremer M, Judd J, Rifkin B, Auszmann J, Oursler MJ (1995) Estrogen modulation of osteoclast lysosomal enzyme secretion. J Cell Biochem 57:271–279

    Article  PubMed  CAS  Google Scholar 

  45. Dempster OW, Moonga BS, Stein LS, Horbert WR, Antakly T (1997) Glucocorticoids inhibit bone resorption in isolated rat osteoclasts by inducing apoptosis. J Endocrinol 154:397–406

    Article  PubMed  CAS  Google Scholar 

  46. Harris M (1993) Central giant cell granulomas of the jaws regress with calcitonin therapy. Br J Oral Maxillofac Surg 31:89

    Article  PubMed  CAS  Google Scholar 

  47. Pogrel MA (2003) Calcitonin therapy for central giant cell granuloma. J Oral Maxillofac Surg 61:649–653

    Article  PubMed  CAS  Google Scholar 

  48. de Lange J, Rosengerg AJWP, van der Akker HP, Koole R, Wirds JJ, van der Berg H (1999) Treatment of CGCG of the jaw with calcitonin. Int J Oral Maxillofac Surg 28:372–376

    Article  PubMed  Google Scholar 

  49. O’Regan EM, Gibb DH, Odell EW (2001) Rapid growth of giant cell granuloma in pregnancy treated with calcitonin. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 92:532–538

    Article  PubMed  Google Scholar 

  50. Pogrel MA, Regezi JA, Harris ST et al (1999) Calcitonin treatment for central giant cell granulomas of the mandible: report of two cases. J Oral Maxillofac Surg 57:848

    Article  PubMed  CAS  Google Scholar 

  51. de Lange J, van der Akker HP, van der Berg H, Richel DJ, Gortzak RA (2006) Limited regression of central giant cell granuloma by interferon alpha after failed calcitonin therapy: a report of 2 cases. Int J Oral Maxillofac Surg 35:865–869

    Article  PubMed  Google Scholar 

  52. Kaban KB, Mulliken JB, Ezekowitz RA, Ebb D, Smith PS, Folkman J (1999) Antiangiogenic therapy of a recurrent giant cell tumour of the mandible with interferon alpha-2a. Paediatrics 103:11145–11149

    Article  Google Scholar 

  53. Dominguez CL, Martinez GC, Plasencia DJ, Suner M (2004) Intranasal calcitonin therapy for central giant cell granuloma. J Craniomaxillofac Surg 32(supp 1):244–245

    Google Scholar 

  54. Kaban LB, Troulis MJ, Ebb D, August M, Hornicek FJ, Dodson TB (2002) Antiangiogenic therapy with interferon alpha for giant cell lesions of the jaws. J Oral Maxillofac Surg 60:1103–1111

    Article  PubMed  Google Scholar 

  55. Brouty-Boye D, Zetter B (1980) Inhibition of cell motility by interferon. Science 208:516

    Article  PubMed  CAS  Google Scholar 

  56. Sidky YA, Borden EC (1987) Inhibition of angiogenesis by interferons: effects on tumour- and lymphocyte-induced vascular responses. Cancer Res 47:5155

    PubMed  CAS  Google Scholar 

  57. White CW, Sondheimer HM, Crouch EC et al (1989) Treatment of pulmonary haemangiomatosis with recombinant interferon alpha-2a. N Engl J Med 320:1197

    Article  PubMed  CAS  Google Scholar 

  58. de Lange J, van Maarle MC, van den Akker HP et al (2007) DNA analysis of the SH3BP2 gene in patients with aggressive central giant cell granuloma. Br J Oral Maxillofac Surg 45:499

    Article  PubMed  Google Scholar 

  59. Tallan EM, Olsen KD, McCaffrey TV et al (1994) Advanced giant cell granuloma: a twenty-year study. Otolaryngol Head Neck Surg 110:413

    PubMed  CAS  Google Scholar 

  60. Landesberg R, Eisig S, Fennoy I et al (2009) Alternative indications for bisphosphonate therapy. J Oral Maxillofac Surg 67(Suppl 1):27

    Article  PubMed  Google Scholar 

  61. de Lange J, van Rijn RR, van den Berg H et al (2009) Regression of central giant cell granuloma by a combination of imatinib and interferon: a case report. Br J Oral Maxillofac Surg 47:59

    Article  PubMed  Google Scholar 

  62. Orchard PJ, Smith CM, Woods WG et al (1989) Treatment of haemangioendotheliomas with alpha interferon. Lancet 2:565

    Article  PubMed  CAS  Google Scholar 

  63. Ezekowitz RAB, Mulliken JB, Folkman J (1992) Interferon alpha-2a therapy for life-threatening hemangiomas of infancy. N Eng J Med 326:1456 (erratum appears in N Engl J Med 1994, volume ID 330, p 300)

    Article  CAS  Google Scholar 

  64. Hatley RM, Sabio H, Howell CG et al (1993) Successful management of an infant with a giant hemangioma of the retroperitoneum and Kasabach-Merritt syndrome with alpha-interferon. J Pediatr Surg 28:1356

    Article  PubMed  CAS  Google Scholar 

  65. Chang E, Boyd A, Nelson CC et al (1997) Successful treatment of infantile hemangiomas with interferon alpha-2b. J Pediatr Hematol Oncol 19:237

    Article  PubMed  CAS  Google Scholar 

  66. Yasko AW (2001) Interferon therapy for vascular tumors of bone. Curr Opin Orthop 12:514

    Article  Google Scholar 

  67. Abukawa H, Kaban LB, Vacanti J et al (2002) Effect of interferon on porcine mesenchymal stem cells in vitro. J Dent Res 81:531–535

    Article  Google Scholar 

  68. Abukawa H, Kaban LB, Williams WB et al (2006) Effect of interferon alpha-2b on porcine mesenchymal stem cells. J Oral Maxillofac Surg 64:1214

    Article  PubMed  Google Scholar 

  69. Goldman KE, Marshall MK, Alessandrini E, Bernstein ML (2005) Complications of alpha-interferon therapy for aggressive giant cell lesion of the maxilla. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 100:285–291

    Article  PubMed  Google Scholar 

  70. Barlow CF, Priebe CJ, Mulliken JB et al (1988) Spastic diplegia as a complication of interferon alfa-2a treatment of hemangiomas of infancy. J Pediatr 132:527

    Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Department of Oral and Maxillofacial Surgery, St James’s Hospital, Dublin, Ireland

    J. E. O’Connell & G. J. Kearns

Authors
  1. J. E. O’Connell
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. J. Kearns
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J. E. O’Connell.

Rights and permissions

Reprints and permissions

About this article

Cite this article

O’Connell, J.E., Kearns, G.J. Aggressive giant cell granuloma of the jaws treated with interferon alpha: a report of two cases. Ir J Med Sci 182, 163–170 (2013). https://doi.org/10.1007/s11845-012-0858-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11845-012-0858-x

Keywords

Search

Navigation